W. Okamura

发表

Profile of ligand specificity of the vitamin D binding protein for 1α,25‐dihydroxyvitamin d3 and its analogs

A. Norman, E. D. Collins, J. Bishop, 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

1α,25‐Dihydroxy‐3‐Epi‐vitamin D3, a natural metabolite of 1α,25‐dihydroxyvitamin D3, is a potent suppressor of parathyroid hormone secretion

Alex J. Brown, E. Slatopolsky, C. Ritter, 1999 .

Development of a novel 1,25(OH)2-vitamin D3 analog with potent ability to induce HL-60 cell differentiation without modulating calcium metabolism.

H. Koeffler, M. Akashi, M. Uskoković, 1991, Blood.

1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.

H. Koeffler, Y. Y. Lee, L. Binderup, 1994, Blood.

Myeloid Differentiation Mediated Through New Potent Retinoids and Vitamin D3 Analogs

H. Koeffler, M. Dawson, M. Uskoković, 1996 .

1α,25‐Dihydroxy‐3‐epi‐vitamin D3: In vivo metabolite of 1α,25‐dihydroxyvitamin D3 in rats

M. Uskoković, P. Vouros, W. Okamura, 1999 .

Biochemical Significance of the 6‐s‐cis Conformation of the Steroid Hormone lα,25‐Dihydroxyvitamin D3 Based on the Provitamin D Skeleton a

A. Norman, I. Nemere, W. Okamura, 1995, Annals of the New York Academy of Sciences.

Structure-function relationships in the vitamin D endocrine system.

R. Bouillon, A. Norman, R Bouillon, 1995, Endocrine reviews.

Identification of a specific binding protein for 1 alpha,25-dihydroxyvitamin D3 in basal-lateral membranes of chick intestinal epithelium and relationship to transcaltachia.

A. Norman, I. Nemere, W. Okamura, 1994, The Journal of biological chemistry.

Comparison of 6-s-cis- and 6-s-trans-locked analogs of 1alpha,25-dihydroxyvitamin D3 indicates that the 6-s-cis conformation is preferred for rapid nongenomic biological responses and that neither 6-s-cis- nor 6-s-trans-locked analogs are preferred for genomic biological responses.

R. Bouillon, A. Norman, M. Farach-Carson, 1997, Molecular endocrinology.

Demonstration that 1 beta,25-dihydroxyvitamin D3 is an antagonist of the nongenomic but not genomic biological responses and biological profile of the three A-ring diastereomers of 1 alpha,25-dihydroxyvitamin D3.

R. Bouillon, A. Norman, M. Farach-Carson, 1993, The Journal of biological chemistry.

Nonnuclear effects of the steroid hormone 1 alpha,25(OH)2-vitamin D3: analogs are able to functionally differentiate between nuclear and membrane receptors.

A. Norman, I. Nemere, W. Okamura, 1994, Biochemical and biophysical research communications.

Structure-function studies of 1,25-dihydroxyvitamin D3 and the vitamin D endocrine system. 1,25-dihydroxy-pentadeuterio-previtamin D3 (as a 6-s-cis analog) stimulates nongenomic but not genomic biological responses.

R. Bouillon, A. Norman, M. Farach-Carson, 1993, The Journal of biological chemistry.

Production of 1alpha,25-dihydroxy-3-epi-vitamin D3 in two rat osteosarcoma cell lines (UMR 106 and ROS 17/2.8): existence of the C-3 epimerization pathway in ROS 17/2.8 cells in which the C-24 oxidation pathway is not expressed.

M. Uskoković, A. Norman, P. Vouros, 1999, Bone.